Clinical Trial: Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07581145) titled 'Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients' on April 24.

Brief Summary: The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients.

It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.

Study Start Date: April 24

Study Type: INTERVENTIONAL

Condition: Foot Ulcer Due to Type 2 Diabetes Mellitus

Intervention: DRUG: Semaglutide, 1.34 mg/mL

pen for subcutaneous injections

DRUG: Placebo

pen for subcutaneous injections

Recruitment Status: RECRUITIN...